Non-invasive liver fibrosis markers in the evaluation of fibrosis regression after direct-acting antiviral (DAA) therapy. Collazos J, Asensi V. J Infect Dis 2024 Feb 23:jiae095. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Collazos J, Asensi V. Non-invasive liver fibrosis markers in the evaluation of fibrosis regression after direct-acting antiviral (DAA) therapy. J Infect Dis 2024 Feb 23:jiae095. doi: 10.1093.
PMID: 38394618